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ABSTRACT 
Vibrio vulnificus and Vibrio parahaemolyticus are both bacteria that cause human 
infection. V. vulnificus has a polysaccharide locus, rbd, responsible for bacterial 
aggregation, a form of biofilm. This locus is conserved in V. parahaemolyticus and in the 
non-pathogen V. fischeri.  
In V. fischeri, the polysaccharide locus, syp, has been extensively characterized 
and shown to be important for biofilm formation. In V. fischeri, the first gene, sypA, is 
critical for biofilm formation. V. fischeri biofilm-proficient strains form wrinkled 
colonies. In contrast, sypA mutants form smooth colonies, indicating a lack of biofilm 
formation.  
 To understand the function of RbdA and SypAVP, proteins encoded by the first 
genes in the respective polysaccharide loci, in biofilm formation, we hypothesized we 
could use the well-characterized V. fischeri model of biofilm formation. I found that rbdA 
and sypAVP are able to promote biofilm formation in V. fischeri. Additionally, RbdA and 
SypAVP function appear to be controlled by SypE, the negative regulator of SypA in V. 
fischeri.       
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CHAPTER ONE  
LITERATURE REVIEW 
 
I. Introduction 
Vibrio vulnificus is a halophilic bacterium naturally occurring in marine and estuarine 
environments. Vibrio parahaemolyticus is also a halophilic bacterium. It is found 
naturally in warm, brackish saltwater in coastal waters around the United States and 
Canada. Both bacteria are opportunistic human pathogens that can cause gastrointestinal 
and severe wound infections [1]. Many factors allow these bacteria to cause disease in 
humans. One likely factor is the ability to form a biofilm. A biofilm may form in the 
environment, for example, on an oyster. Biofilms that are not removed from oysters that 
are harvested for human consumption may increase the transmission of bacteria to the 
human host [2]. A biofilm may also form in the human host, causing persistent infection 
[3]. Both bacteria encode genes for the production and transport of a polysaccharide that 
may contribute to the formation of the biofilm, but the individual genes of these loci have 
not been characterized [4].  
Vibrio fischeri is a related, non-pathogenic Vibrio species that is a symbiont of the 
Hawaiian bobtail squid, Euprymna scolopes. To efficiently colonize the squid, Vibrio 
form a biofilm. Biofilm formation is dependent on an 18-gene locus called syp [5, 6]. 
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Genes involved in forming the biofilm and associated behaviors have been 
extensively characterized. The first gene in the syp locus encodes a STAS domain 
protein, which is a regulator of biofilm formation. The first genes in the V. vulnificus and 
V. parahaemolyticus loci also encode STAS domain proteins. Therefore, V. fischeri 
biofilm formation serves as a model for the study of biofilm formation in other related 
Vibrio species. Biofilms are of clinical significance and how a model organism forms a 
biofilm could provide insight into the pathogenesis of bacteria that form biofilms. 
 
II. Vibrio vulnificus 
Clinical significance 
 Disease associated 
V. vulnificus is an opportunistic pathogen that can cause disease in healthy 
individuals in two ways: via ingestion of contaminated food such as raw seafood, 
particularly oysters, or via exposure of an open wound to infected seawater. In healthy 
individuals, ingestion of V. vulnificus can cause infection with symptoms ranging from 
vomiting to diarrhea to abdominal pain. The initial gastrointestinal infection can become 
systemic, causing a serious disease with symptoms including fever, chills, decreased 
blood pressure, and culminating in septic shock. Infection can also cause a blistering 
dermatitis. Systemic infection is more likely to occur in immunocompromised individuals 
than healthy patients. V. vulnificus can also cause infection when bacteria living in 
seawater come into contact with an open wound. In the wound route of infection, disease 
can lead to skin breakdown and ulceration. Systemic infection stemming from a wound 
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infection can result in complications with symptoms similar to the systemic 
gastrointestinal infection [1].  
Immunocompromised individuals are susceptible to a variety of infections that 
normally pose little risk to healthy individuals. Certain medical conditions, such as liver 
dysfunction and other syndromes that lead to increased iron deposition, including as 
chronic cirrhosis, hepatitis, thalassemia major, hemochromatosis, and heavy alcohol 
consumption, predispose individuals to infection by V. vulnificus through either route of 
infection, ingestion or contact [7]. In immunocompromised individuals with V. vulnificus-
infected wounds, there is a higher risk for bloodstream invasion, and individuals can 
suffer from serious complications, including potentially death. Infections that become 
systemic can have a mortality rate as high as 50%. [1]. 
Incidence 
V. vulnificus is an underreported cause of disease, in part because reporting is 
only required in a subset of states in the U.S.. Most cases occur in the Gulf Coast. The 
Center for Disease Control reports there were more than 900 cases between 1998 and 
2006 in the Gulf Coast [1]. The number of infections in this time period increased 78%. 
There are an average of 50 culture-confirmed cases per year. On average, there are 45 
hospitalizations and 16 deaths reported per year just from the Gulf Coast, which includes 
the states of Alabama, Florida, Louisiana, Mississippi, and Texas. For the nation, there 
are approximately 95 cases reported per year; however, only half of those cases are 
culture-confirmed. Nationwide, there are 85 hospitalizations and 35 deaths [1].  
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V. vulnificus infections and outbreaks occur worldwide. In Japan, there is an 
estimated occurrence of 425 cases of V. vulnificus per year, although the infection is not 
reportable in that country [8]. Japan’s warm coastal waters make it an ideal environment 
for the growth of V. vulnificus. Japan also has a higher rate of raw seafood consumption 
increasing the likelihood of potential infection [9].  
Pathogenesis 
 Those with pre-existing medical conditions, including those with chronic liver 
disease, are 80 times more likely to develop bloodstream infections [1]. Septicemic 
infections occur upon bacterial invasion of the intestinal mucosa. From the intestinal 
mucosa, bacteria can enter the bloodstream [7]. There are two hallmarks of V. vulnificus 
disease: extreme destruction of host tissues and rapid proliferation of the bacteria. While 
virulence factors associated with the bacteria have been identified, little is known about 
what directly contributes to the hallmarks of disease [10]. 
Virulence factors 
The most important virulence factor for V. vulnificus is the production of capsular 
polysaccharide (CPS), which protects the bacteria from host responses such as 
complement and phagocytosis by host immune cells [10]. V. vulnificus strains that do not 
form a capsule are attenuated in mouse models. These strains are also susceptible to 
human serum that contains bactericidal activity. Unfortunately, the antigenicity of the 
capsule can vary among different strains, making the capsule a poor vaccine target [9].  
The ability to acquire iron from the environment is considered another important 
virulence factor of V. vulnificus. There is increased infection susceptibility and disease 
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severity in hosts with increased iron levels. To cause severe infection, the bacterium 
relies on iron imbalance or on factors than cause an iron imbalance [11]. Work in the role 
of iron in V. vulnificus is ongoing, but evidence suggests that iron manipulation by the 
bacteria can have two effects. One effect is that high iron levels can inhibit host 
responses, such as inhibiting neutrophil function. High iron can also significantly 
increase bacterial replication in skin tissue [12]. How either of these mechanisms occurs 
has yet to be elucidated. 
V. vulnificus uses a flagellum for motility. Mutants defective flagellar components 
have been assessed for virulence and a range of defects have been observed. One such 
mutation in the flagellar gene flgC resulted in a strain that was attenuated when orally 
inoculated in mice. Attenuation could be a result of decreased motility or a result of 
decreased adherence. flgC mutant strains also have decreased adherence to cells [13]. 
Another flagellar mutant, fliP, was also non-motile and attenuated in mice. This mutant 
was able to cause severe skin infection but not systemic infection [9]. The difference 
between the two mutants and their ability to cause infection suggests that there may be 
other factors that contribute to the pathogenicity of the organism. 
Other virulence factors of V. vulnificus include hemolysins, cytolysins, and 
metalloproteases [9]. When these secreted proteins are purified and injected into animals, 
some of the pathology of infection can be replicated. Injection of purified hemolysin 
causes skin damage by forming pores in host cell membranes. The formation of pores can 
lead to vasodilation and edema in blood vessels, symptoms that resembles those that 
occur during infection. When a purified metalloprotease was injected into mice, it caused 
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dermal necrosis, increased vascular permeability, and edema. However, when the gene 
for either the metalloprotease or a hemolysin or cytolysin was mutated in V. vulnificus, 
the mutant showed little attenuation in an animal model [9].  
Other putative virulence factors have been identified, including the RtxA toxin 
and pili. The RtxA toxin causes depolymerization of actin in HeLa cells in a contact-
mediated manner. The toxin causes pore formation in red blood cells and necrosis in 
hepatic cells. In a mouse model, however, an rtxA mutant was not attenuated. The 
presence of pili is associated with epithelial cell adherence. Pili mutants no longer 
produce pili or, surprisingly, hemolysin or cytolysin. Chitinase secretion is also inhibited 
in pili mutants. This mutant was attenuated in mice but the reason for attenuation may be 
due to the lack of hemolysin or cytolysin or chitinase secretion [9].   
Economic and environmental burden 
One of the primary vectors of infection with V. vulnificus is the oyster. Oysters 
can only be legally harvested from waters free from fecal contamination. However, V. 
vulnificus can be present in non-fecal contaminated waters as it is a natural inhabitant of 
marine environments. The presence of the bacteria does not alter the appearance, taste, or 
odor of the oysters. Infections are reported to the Food and Drug Administration, which 
identifies the source of infection, preventing further infection in humans. These efforts 
can help predict environmental factors that increase the chance that oysters carry 
pathogens [1]. The increase in reported infections could be due to climate change 
resulting in increased marine temperatures. While there have been more cases of 
infection, the rate of infection has not increased [14]. 
 
 
7 
 
Studies determining differences between clinical and environmental isolated 
strains are ongoing. Studies have found that oyster isolates have the ability to cause 
disease in mice, although clinically isolated strains had a higher prevalence of causing 
systemic infection in mice. In the clinic however, wound infections do not always 
progress to systemic disease. These results suggest that there is a difference between 
strains that cause systemic infection and those that cause wound and gastrointestinal 
infections only. Thus, there appear to be different populations of V. vulnificus, a 
population that can cause destruction and localized infection and a population that causes 
systemic infection. The factors that distinguish the two bacterial populations have yet to 
be identified [9]. The differences in host populations that become infected with either 
wound infections or gastrointestinal infections have yet to be identified as well. 
 
III. Vibrio parahaemolyticus 
Clinical significance 
Disease associated 
 V. parahaemolyticus can cause disease in humans who ingest seafood, including 
raw or undercooked shellfish particularly oysters, contaminated with the bacteria. 
Symptoms of the illness caused by V. parahaemolyticus include abdominal cramping, 
nausea, vomiting, fever, and chills. Symptoms usually occur 24 hours after ingestion of 
contaminated food. Infection is self-limiting lasting on average three days. 
Immunocompromised individuals and those with weakened immune systems can have 
more severe and prolonged illnesses. Medical conditions including alcoholism and liver 
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disease may increase the risk of severe and prolonged disease. Wound infections can also 
occur when an open wound is exposed to infected warm seawater; however, this route of 
infection is less common. Infection rarely spreads to the bloodstream [15]. 
Incidence 
V. parahaemolyticus was first discovered after a food poisoning outbreak in Japan 
in 1950. The outbreak affected 272 individuals making V. parahaemolyticus one of the 
leading causes of foodborne illnesses [16]. In Asian countries such as Taiwan and Japan, 
consumption of raw seafood is not uncommon leading to higher rates of infection [2]. 
In 1971, the United States had its first V. parahaemolyticus outbreak in Maryland 
after individuals consumed infected crabmeat [17]. The CDC estimates that there are 
4500 cases of V. parahaemolyticus infection each year. The number of cases is 
underreported as the disease is self-limiting, preventing many people from seeking 
medical attention. Additionally, laboratories rarely use the selective media required to 
identify V. parahaemolyticus. There are approximately 215 culture-confirmed cases, 30 
hospitalizations, and 1-2 deaths reported each year to the CDC [15]. 
Pathogenesis 
 V. parahaemolyticus causes infection by invading the intestinal epithelia of 
humans after ingestion of contaminated seafood such as shellfish or oysters [15]. Bacteria 
adhere to the intestinal epithelia [18]. The bacteria then inject toxins into the host cells 
via a type III secretion system; these toxins can cause a change in the ion flux in the cell, 
ultimately leading to cell death. Cell death and alterations in the ion flux of the cell cause 
the symptoms that manifest in the clinic [2]. 
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Virulence factors 
 The thermostable direct hemolysin (TDH) is an important virulence factor of V. 
parahaemolyticus. This hemolysin is responsible for the beta-hemolysis seen when 
bacteria are grown on blood agar plates [19]. TDH is a pore-forming toxin that alters the 
ion flux in intestinal cells. This alteration causes diarrhea. Other TDH-related hemolysins 
have been identified. These toxin-like proteinaceous substances can cause death in mice 
at high concentrations and diarrhea at low concentrations. Both toxins have been isolated 
in clinical strains of V. parahaemolyticus that cause gastroenteritis; however, the genes 
for these toxins are missing from most environmental isolates [2]. 
 The ability to hydrolyze urea is another important virulence factor of V. 
parahaemolyticus. Although the role of urease activity in pathogenicity is unclear, urease 
activity has been correlated with the presence of TDH [2]. Like V. vulnificus, an 
important virulence factor for V. parahaemolyticus is the ability to acquire iron. 
Vibrioferrin is a novel siderophore that may provide bacteria with a competitive 
advantage for surviving in an iron-limited environment [20]. It has been previously 
shown that strains grown in iron-limiting conditions exhibited greater adherence, 
increased hemolysis, and higher rates of proliferation [21, 22]. 
Investigators hypothesize that bacteria first adhere to host cells and then produce 
toxins, thus causing disease. V. parahaemolyticus produces heat-stable somatic O 
antigens (lipopolysaccharide), heat-labile capsular K antigens (capsular polysaccharide), 
and H antigens (flagellar antigens) [18]. Recent studies have shown that strains grown in 
the presence of bile or deoxycholate had increased capsule size and exhibited increased 
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adherence to epithelial cells [18]. The in vitro concentrations of bile and deoxycholate 
used in this study are within the physiologic range found in humans, suggesting that the 
presence of bile and deoxycholate could have effects on V. parahaemolyticus capsular 
size, and therefore adherence, during human infection. In other enteric bacteria, it has 
been previously shown that increased capsular size correlates to increased virulence. In V. 
parahaemolyticus, the increased capsule and increased adherence could allow the 
bacteria to aggregate and adhere to intestinal cells, thus promoting disease [18]. 
 Emerging data suggest that the presence of a type III secretion system within a 
pathogenicity island plays a role in V. parahaemolyticus virulence. Type III secretion 
systems have been shown in other bacteria to function in the export of bacterial virulence 
factors into host cells. Vibrio cholerae is a related pathogenic bacterium that, like V. 
parahaemolyticus, causes diarrheal diseases. In V. parahaemolyticus infection, diarrhea is 
considered an inflammatory response [2]. In V. cholerae, the response is non-
inflammatory [23], suggesting there could be two different mechanisms of action causing 
diarrhea by Vibrio species. This difference could in part be explained by the presence of a 
type III secretion system. V. cholerae does not encode a type III secretion system. It is 
hypothesized that the presence of the type III secretion system is important in disease that 
results in a non-inflammatory response [2]. 
Environmental and economic burden 
V. parahaemolyticus infections occur seasonally with 70% of infections occurring 
between the months of May and October due to warmer water temperatures, which are 
optimal for bacterial growth. Large outbreaks have been linked to the consumption of 
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oysters. Environmental factors, such as warm water and moderate salinity, caused an 
increase in the number of V. parahaemolyticus organisms in shellfish and thus played a 
role in the outbreaks in 1997, 1998, and 2006 [15].   
 Several techniques are employed to ensure the removal of potentially harmful 
bacteria from shellfish populations. Relaying, a technique used to purify oysters, involves 
transferring contaminated shellfish from restricted areas to approved natural biological 
purification areas. Depuration, another oyster purifying technique, involves the same 
process except contaminated shellfish are transferred to a controlled aquatic environment 
instead of a natural environment. Several techniques have been employed to decrease 
bacterial load post-harvest as the bacteria can rapidly replicate while shellfish are held at 
room temperature. Mild heat treatment, low temperature pasteurization, high-pressure 
processing, and low dose irradiation can reduce the number of bacteria associated with 
oysters. Strains of V. parahaemolyticus have different sensitivities to treatments. Finding 
a treatment or combination of treatments that eliminates all strains of V. 
parahaemolyticus is ongoing in the oyster industry [2]. 
 
IV. Vibrio fischeri 
Symbiotic relationship 
 Vibrio fischeri is a non-pathogenic Vibrio species. The bacterium is a symbiont of 
the Hawaiian bobtail squid, Euprymna scolopes. The bacterium colonizes the light organ 
of the juvenile squid. The colonization is highly specific as V. fischeri is the only 
colonizer of the squid organ despite the number of the closely related bacteria present in 
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the seawater [24]. One step in early colonization involves the formation of a biofilm on 
the surface of the squid’s symbiotic organ, the light organ [6, 25, 26]. Biofilm formation 
is required for V. fischeri to efficiently colonize its symbiotic host, and depends on a 
cluster of genes called the syp locus, for symbiosis polysaccharide locus [5, 6].  
 
V. Bacterial Biofilm Formation 
Stages of biofilm formation 
A biofilm is a complex community of microorganisms that adhere to each other 
and, typically, to a surface. Bacteria within the biofilm are embedded in a matrix 
consisting of polysaccharides and other molecules such as proteins and DNA. The matrix 
can protect commensal and pathogenic bacteria from environmental stresses, such as 
antibiotics, as well as from host responses [27, 28]. Other polysaccharides, such as 
capsular polysaccharides, produced by bacteria can protect the bacteria from host 
responses and allow them to stick to host cells [14].  
Biofilms form when free-living bacterial cells respond to environmental cues that 
trigger changes in gene expression that allow bacteria to attach to surfaces. The initial 
interaction between the bacterial cells themselves and between the cells and a surface 
occurs when any of a variety of cell structures ranging from pili to polysaccharides 
promote attachment. After attachment, the biofilm matures. This stage is marked by two 
properties: increased exopolysaccharide production and increased antibiotic resistance. 
During biofilm maturation, bacteria may develop additional properties such as increased 
resistance to UV light, increased rates of genetic exchange, increased secondary 
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metabolite production, and altered biodegradative capabilities. The last stage of biofilm 
formation involves detachment from the biofilm. In a patient, this detachment can allow 
bacteria to disseminate to another site, form a biofilm, and cause persistent disease. The 
molecular mechanisms underlying these changes are an active area of research [29]. 
Clinical relevance of biofilm formation 
 Biofilms allow bacteria not only to colonize human hosts growing on prosthetic 
devices and catheters, causing persistent infection, but also promote their survival. 
Bacteria within biofilms pose a threat in the clinical setting because bacteria exhibit a 
decreased susceptibility to antimicrobial agents. This could be an intrinsic property of the 
bacteria or it could be an acquired property. Transfer of antibiotic resistance genes 
between different populations of bacteria within the biofilm could give the bacteria a 
survival advantage when faced with antimicrobial agents. Bacteria within a biofilm are 
often more resistant to antibiotics than planktonic cells. The differences in antibiotic 
susceptibilities between cell types can be problematic in the laboratory setting as 
antimicrobial susceptibility testing is done on planktonic cells. The microdilution testing 
that is used in the clinical laboratory does not accurately determine the susceptibility of 
bacteria within the biofilm [3]. 
 Most bloodstream infections are caused by the release of bacteria from the biofilm 
on an indwelling catheters, prosthetics, or other indwelling medical devices. Bloodstream 
infections originating from an infection of an indwelling catheter are most often caused 
by a biofilm forming on the indwelling medical device. Greater understanding of how 
biofilms form on indwelling devices can provide insight on how to treat infections [3]. 
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Biofilm formation and aggregation in V. vulnificus 
Biofilm formation by bacteria in a human host can have serious consequences in 
the clinical setting. The production of polysaccharides plays a large role in biofilm 
formation, and phenotypes of biofilm formation can be measured in the lab by the 
production of rugose colonies, pellicles, or aggregate formation [4]. V. vulnificus has two 
polysaccharide loci that have been studied. One polysaccharide locus, designated rbd for 
regulation of biofilm development, is responsible for bacterial aggregation [4]. Wild-type 
strains of V. vulnificus are able to form biofilms on glass slides and on the surface of a 
crab shell. However, when the rbd locus was disrupted, V. vulnificus strains formed a less 
extensive biofilm on either surface suggesting the rbd polysaccharide locus is important 
for the formation of the biofilm. In contrast, disruption of the rbd locus did not impact 
rugose phenotype, suggesting that the rbd locus is not important for this phenotype. 
Indeed, disruption of a second polysaccharide locus, brp (for biofilm and rugose 
polysaccharide), which was previously shown to be involved in biofilm formation, 
abolished the rugose phenotype [4].  
Further studies determined the rbd locus was, instead, important for aggregation. 
To evaluate aggregation, researchers grew wild-type stains and rbd-overexpressing 
strains overnight, and then allowed the cultures to sit for 5 seconds or 5 minutes. Wild-
type stains of V. vulnificus formed little to no ring on the sides of the culture tube, while 
the rbd-overexpressing strains produced a biofilm ring on the sides of the culture tube. 
Strains overexpressing rbd also formed a visible cell aggregate. The same experiments 
tested the ability of brp-overexpressing strains to form aggregates. In combination with 
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the rugose phenotype experiments, it was concluded that rbd has a more dramatic effect 
on aggregation, while brp has greater impact on rugosity [4]. These studies suggest that 
V. vulnificus can form different biofilms using different polysaccharides.  
In other studies, investigators sought to determine the contribution of the rbd 
polysaccharide locus to disease in a mouse model. It was found that when mice were 
infected with a V. vulnificus strain in which the rbd locus was disrupted, there was no 
effect in attenuation in mouse lethality. Although work to date has not revealed a role for 
rbd in mouse colonization, it remains possible that this locus may be one of the factors 
that contribute to persistence in the oyster population [30]. rbd may be triggered to 
enhance colonization of the oyster, or other shellfish, by enabling the dissemination of 
aggregates of bacteria that can be easily retained by the filter-feeding host or captured 
from the water environment [4]. 
Conservation and role of polysaccharides in biofilm formation 
To produce a biofilm, bacteria secrete an extracellular matrix that holds the 
bacterial community together. One component of the extracellular matrix is 
polysaccharide [31]. The rbd locus, which encodes genes for the production and transport 
of a polysaccharide, in V. vulnificus has been shown to be involved in aggregation. This 
polysaccharide locus is conserved in V. parahaemolyticus as well as in the non-
pathogenic V. fischeri. When induced to form a biofilm, V. fischeri produces the Syp 
polysaccharide, and this biofilm formation in V. fischeri depends on Syp polysaccharide 
production [6].  When the syp locus is expressed, V. fischeri produces wrinkled colonies, 
pellicles, and extracellular matrix. When any of the syp genes are lost, the wild-type 
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phenotype is restored as no wrinkled colonies are produced, and no extracellular matrix 
appears to be present [25].  
Additionally, disruption of the syp locus abolishes colonization [6, 25, 26]. The 
syp cluster can be over-expressed in vitro to permit the study of biofilm formation [26]. 
When a regulator of the syp locus is over-expressed, strains of V. fischeri form wrinkled 
colonies when spotted on to agar plates and form pellicles in static liquid culture (Figure 
1).  
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Figure 1. Transcriptional regulation of the syp locus. The histidine kinase RscS acts upstream 
of the syp-encoded response regulator SypG to control syp transcription. RscS is activated and 
autophosphorylates upon sensing an unidentified signal and serves as a phosphodonor for SypG. 
Phosphorylated SypG activates transcription of the individual operons. Transcription of the locus 
leads to polysaccharide production, which in turn leads to the formation of wrinkled colonies 
when cells are grown on agar plates. 
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The first gene in the polysaccharide locus in V. fischeri is sypA, which encodes the 
protein SypA, a regulator of biofilm formation. SypA has a sulfate transporter and anti-
sigma factor antagonist (STAS) domain. Although the specific function of SypA is 
unknown, this protein is required for biofilm formation by V. fischeri [32, 33]. The 
activity of SypA is regulated by another protein encoded by the polysaccharide locus, 
SypE. SypE phosphorylates a conserved serine residue, serine 56, within a consensus 
sequence of SypA [32].  
 
VI. STAS Domain Proteins 
The first gene encoded in the syp locus is sypA. Interestingly, a STAS domain is 
encoded in the first gene of the rbd locus, rbdA, in V. vulnificus and in the first gene of 
the V. parahaemolyticus polysaccharide locus, sypAVP. While the individual genes of the 
V. vulnificus locus, including rbdA, have not been well characterized [4], there is much 
known about the V. fischeri STAS domain protein, SypA. In V. fischeri, the STAS 
domain protein, SypA, is a regulator of biofilm formation and is required for 
polysaccharide production and biofilm formation [32, 33]. Although its function is 
unknown, evidence suggests it functions differently from the best studied STAS domain 
proteins. 
Characteristics of STAS domain proteins 
Sulfate transporter and anti-sigma factor antagonist (STAS) domain proteins that have 
been well characterized are typically involved in stress responses in the cell, and the 
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function of STAS domain proteins has been studied in many different bacterial models 
[34]. The first studied STAS domain proteins were single domain anti-sigma factor 
antagonists. This type of STAS domain protein indirectly activates transcription by 
inactivating an inhibitor of transcription such as an anti-sigma factor kinase. The 
inactivation of the anti-sigma factor kinase allows sigma factors to activate transcription 
[35].  
STAS domain proteins have been shown to have a variety of other functions. STAS 
domain proteins can also bind nucleotides. Some interact within a multi-domain protein 
to sense light, oxygen, or other proteins. STAS domain proteins exhibit a conserved fold 
of 4 β sheets interspersed among 5 α helices [35]. 
Role of STAS domain proteins in non-Vibrio species 
i. SpoIIAA 
Bacteria encounter a wide variety of stresses. Some stresses are extreme, and in 
the presence of extreme stress can cause the bacteria to sporulate, as is the case with 
Bacillus subtilis. When B. subtilis is faced with stress, such as starvation, cells begin to 
sporulate. B. subtilis sporulation, the small STAS domain protein, SpoIIAA, interacts 
with the anti-sigma factor SpoIIAB to promote activation of transcription of σF genes that 
lead to sporulation. In this pathway, the anti-sigma factor SpoIIAB binds to σF, 
preventing it from binding polymerase. SpoIIAA binds SpoIIAB. This binding between 
SpoIIAA and SpoIIAB promote a steric and electrostatic clash that leads to the 
dissociation of SpoIIAB from σF, thus permitting activation of sporulation gene 
transcription. SpoIIAA is controlled via phosphorylation. When SpoIIAA is 
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phosphorylated, it dissociates from SpoIIAB. When SpoIIAA is unphosphorylated, the 
protein is able to form a tight complex such that SpoIIAB can no longer bind to σF [35]. 
It is known that when cells are induced to sporulate, the concentrations of GTP 
and GDP significantly decrease. SpoIIAA acts not only as an anti-anti-sigma factor but 
also as a GTP-binding protein. It was also found that SpoIIAA has GTPase and ATPase 
activity. When the site of phosphorylation is mutated in SpoIIAA, the GTPase activity 
was diminished [36]. 
ii. RsbV 
Bacteria also encounter less extreme stresses more frequently. B. subtilis can also 
respond to frequent, moderate stresses it encounters by controlling gene expression 
through use of an anti-sigma factor, RsbW, and an anti-sigma factor antagonist, RsbV. 
When B. subtilis is not stressed, the sigma factor σB is held inactivated in a complex with 
the anti-sigma factor kinase RsbW. When the cell encounters stress in the form of 
temperature, pH, osmolarity, ethanol, blue light changes or cell wall stress, the anti-anti 
sigma factor RsbV can inhibit RsbW [37, 38]. RsbV itself is controlled via 
phosphorylation by RsbW, releasing σB to induce stress response genes. This inhibits the 
anti-anti-sigma activity of RsbV. It can be further dephosphorylated by RsbU which 
restores the anti-anti-sigma activity of RsbV (Figure 2) [35]. 
In addition to the RsbV STAS domain protein, there are other STAS domain 
proteins in this B. subtilis stress response pathway, including RsbR and RsbS. RsbU, 
which is one of the regulators of RsbV activity, is controlled by a complex of proteins 
that integrates several stress signals to effect a single outcome called the stressosome 
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(Figure 2) [35]. The signal transduction cascade increases the expression of genes that 
respond to stress [34]. The stressosome consists of 40 copies of the multidomain STAS 
protein RsbR, 20 copies of the simple STAS domain protein RsbS, and 20 inactive, 
sequestered copies of the switch kinase RsbT [37]. RsbR has a C-terminal STAS domain 
and an N-terminal globulin fold domain that has an as of yet unknown function [35]. 
In response to stress, RsbT phosphorylates RsbR and RsbS, promoting the release 
of RsbT from the stressosome. Free RsbT activates RsbU phosphatase. Active RsbU is 
then able to remove the inhibitory phosphoryl group from RsbV, permitting RsbV to bind 
to RsbW. RsbW releases σB, allowing it to activate RNA polymerase and transcribe the 
σB regulon. The stressosome is inactivated by the dephosphorylation of the stressosome 
proteins RsbS and RsbR by the phosphatase RsbX. This activation of stress response 
genes is highly sensitive with high cooperativity [37, 39]. 
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Figure 2. The Rsb Stressosome. The stressosome, made up of STAS proteins RbsR and RbsS, 
sequesters RsbT. Under stress, RsbT phosphorylates RsbR and RsbS. RsbT is then released and 
free to activate RsbU. The RsbT/RsbU complex dephosphorylates RsbV which is then able to 
bind the anti-sigma factor RsbW. RsbV binding to RsbW liberates σB from the inactivating 
complex with RsbW. Free σB can then bind RNA polymerase to promote gene expression [35]. 
 
 
23 
 
iii. Rv1739c 
STAS domain proteins also play a role in anion transport. Mycobacterium 
tuberculosis has a sulfate or anion transporter that is comprised of a SulP-type 
transmembrane domain and a C-terminal cytoplasmic STAS domain, Rv1793c. When 
purified, Rv1793c was found to bind guanine nucleotides. It was also found that the 
protein had modest GTPase activity. Interestingly, this protein does not serve as a 
phosphorylation target [35]. It has been shown that the Rv1793c undergoes 
conformational changes when bound to either GTP or GDP. The differences in the 
conformation of Rv1793c when bound to either GTP or GDP give more insight into the 
interaction between nucleotides and STAS domain proteins [36]. 
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CHAPTER TWO  
MATERIALS AND METHODS 
 
Strains and Media. Bacterial strains used in this study are listed in Table 1. V. fischeri 
strains were derived by conjugation. Escherichia coli GT115 (Invivogen, San Diego, CA) 
was used for cloning and conjugation experiments [40, 41]. V. fischeri strains were 
cultured in Luria-Bertani salt (LBS) [42].  The following antibiotics were added to LBS 
medium at the indicated concentrations: chloramphenicol (Cm) 2.5 µg ml-1, 
erythromycin at 5 µg ml-1, and tetracycline (Tc) at 5 µg ml-1 in LBS. E. coli strains were 
cultured in Luria Bertani medium (LB) [43]. The following antibiotics were added to LB 
medium at the indicated concentrations: Cm at 25 µg/ml-1, kanamycin (Kan) at 50 µg 
ml-1, Tc at 15 µg/ml-1, or ampicillin (Ap) at 100 µg ml-1. For solid media, agar was 
added to a final concentration of 1.5%. 
Bioinformatics. Amino acid sequences for V. vulnificus RbdA, V. parahaemolyticus 
SypAVP, and V. fischeri SypA were obtained from the National Center for Biotechnology 
Information (NCBI) database. Alignments of RbdA, SypAVP, and SypA were generated 
using the Clustal Omega multiple-sequence alignment program from EMBL-EBI 
(http://ebi.ac.uk/Tools/msa/clustalo) [44]. 
Molecular and genetic techniques. The rbdA and sypAVP alleles used in this study were 
generated by Polymerase Chain Reaction (PCR) using primers listed in Table 2. PCR 
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products were cloned into the plasmid pARM47, a vector for chromosomal insertion at 
the Tn7 site containing the lac promoter [45], that was digested to remove the sypE gene. 
For dual promoter constructs, the homologous sypA genes were cloned downstream of 
the V. fischeri sypA promoter. The Gibson Assembly kit (New England Biolabs) was 
used to generate plasmid constructs for the homologous sypA genes. Alleles were inserted 
into the chromosomal Tn7 site of V. fischeri strains using tetraparental conjugation. To 
generate site-directed mutations in sypA, mutated alleles of sypA were generated by PCR 
using mutagenic primers (Table 3) and the Gibson Assembly kit. The mutations were 
confirmed by sequence analysis using ACGT, inc (Wheeling, IL).  
Wrinkled colony formation assay. To observe wrinkled colony formation, the indicated 
V. fischeri strains were streaked onto LBS agar plates containing the necessary 
antibiotics. Single colonies were then cultured with shaking in LBS broth containing 
antibiotics overnight at either 24°C (for rscS overexpressing strains) or 28°C (for sypG 
overexpressing strains). The strains were then sub-cultured the following day in 5 ml of 
fresh medium. Following growth to early log phase, the cultures were back-diluted in 
LBS to an OD600 of 0.2. 10 µl of diluted cultures were spotted onto LBS agar plates, 
containing necessary antibiotics, and grown at either ~ 24°C (for rscS overexpressing 
strains) or 28°C (for sypG overexpressing strains). Images of the spotted cultures were 
acquired over the course of the developmental process of biofilm formation at the 
indicated time points using a Zeiss stemi 2000-C dissecting microscope. 
Western blot analysis of V. fischeri lysates. V. fischeri strains were cultured in LBS 
containing the appropriate antibiotics overnight at 24 °C. Cultures were standardized to 
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the same amounts using OD600 measurements, concentrated by centrifugation, and lysed 
in 500 µL 2X sample (4% SDS, 40 mM Tris pH 6.3, 10% glycerol) buffer. Samples were 
resolved on either 10 or 15% SDS-PAGE gels (10% 29:1 acrylamide: N, N’-methylene-
bis-acrylamide, 375 mM Tris pH 8.6, 0.1% SDS), and transferred to PVDF membranes. 
SypA and SypA-like proteins were detected by western blot analysis using rabbit anti-HA 
antibody (Sigma-Aldrich, St. Louis, MO) followed by a secondary, donkey anti-rabbit 
IgG antibody (Sigma-Aldrich, St. Louis, MO) conjugated to horseradish peroxidase 
(HRP), and visualized using SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Fischer Scientific, Rockford, IL). 
Assessment of SypA phosphorylation in vivo. Two plasmids were introduced into E. 
coli, one that expressed either rbdA or sypAVP and one that expressed V. fischeri sypE and 
the phosphorylation state of either the RbdA protein or the SypAVP protein was evaluated 
using the Phos-tagTM reagent (Wako Chemicals USA, Inc., Richmond, VA). The Phos-
tagTM reagent retards the migration of phosphorylated proteins. The reagent preferentially 
binds to phosphorylated proteins, thus separating phosphorylated proteins from 
unphosphorylated proteins and, resulting in a band shift observable following gel 
electrophoresis and western blotting. E. coli strains were cultured overnight with shaking 
in LB containing the appropriate antibiotics at 37°C. Cells were sub-cultured the 
following day in 5 ml of fresh medium and grown for 8 hours. Aliquots of cells were 
standardized to the same amounts using OD600 measurements, then concentrated by 
centrifugation. Samples were lysed in 2X SDS sample buffer and resolved on SDS-
PAGE gels containing 25-30 µM Phos-tagTM acrylamide (WAKO Chemicals USA, Inc., 
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Richmond, VA) and 50-60 µM MnCl2. Gels were fixed for 15 min in standard transfer 
buffer containing 1 mM EDTA, and then incubated an additional 20 min in transfer 
buffer without EDTA.  Proteins were transferred to a PVDF membrane and the proteins 
were detected by western blot analysis using either an anti-HA or anti-FLAG antibody 
(Sigma-Aldrich, St. Louis, MO). 
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Table 1: Strains used in this study 
Strains Genotype Reference 
or source 
E. coli   
GT115 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 
endA1 Δdcm uidA(ΔMluI)::pir-116 ΔsbcC-sbcD  
InvivoGen 
   
V. fischeri   
ES114 WT [40] 
KV3299 ΔsypE [26] 
KV4389 attTn7::ermR [46] 
KV4390 ΔsypE attTn7::ermR [46] 
KV4715 ΔsypA [32] 
KV4716 ΔsypA ΔsypE [32] 
KV5079 ΔsypA attTn7::ermR [32] 
KV5479 ΔsypA attTn7::sypA [32] 
KV6392 ΔsypA ΔsypE attTn7::ermR [32] 
KV6393 ΔsypA ΔsypE attTn7::sypA [32] 
KV6578 ΔsypA attTn7::sypA-HA  [47] 
KV6579 ΔsypA attTn7::sypAS56A HA [47] 
KV6580 ΔsypA ΔsypE attTn7::sypA-HA [47] 
KV6581 ΔsypA ΔsypE attTn7::sypAS56A HA [47] 
KV6993 ΔsypA ΔsypE attTn7::sypAK67A HA Sheila 
McEwen 
KV6995 ΔsypA attTn7::sypAK67A HA Sheila 
McEwen 
KV6998 ΔsypA ΔsypE attTn7::sypAQ84A HA Sheila 
McEwen 
KV7000 ΔsypA attTn7::sypAQ84A HA Sheila 
McEwen 
KV7003 ΔsypA ΔsypE attTn7::sypAR68A HA Sheila 
McEwen 
KV7005 ΔsypA attTn7::sypAR68A HA Sheila 
McEwen 
KV7008 ΔsypA ΔsypE attTn7::sypAR93A HA Sheila 
McEwen 
KV7010 ΔsypA attTn7::sypAR93A HA Sheila 
McEwen 
KV7169 ΔsypA attTn7::rbdA plac only This Study 
KV7170 ΔsypA attTn7::sypAVP plac only This Study 
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KV7172 ΔsypA ΔsypE attTn7::rbdA plac only This Study 
KV7173 ΔsypA ΔsypE attTn7::sypAVP plac only This Study 
KV7309 ΔsypA attTn7::rbdA plac and psypA This Study 
KV7310 ΔsypA ΔsypE attTn7::rbdA plac and psypA This Study 
KV7313 ΔsypA attTn7::sypAVP plac and psypA This Study 
KV7314 ΔsypA ΔsypE attTn7::sypAVP plac and psypA This Study 
KV7315 ΔsypA attTn7::sypAVP-HA plac and psypA This Study 
KV7316 ΔsypA ΔsypE attTn7::sypAVP-HA plac and psypA This Study 
KV7325 ΔsypE attTn7::rbdA plac and psypA This Study 
KV7326 attTn7::rbdA plac and psypA This Study 
KV7327 ΔsypE attTn7::sypAVP plac and psypA This Study 
KV7328 attTn7::sypAVP plac and psypA This Study 
KV7558 ΔsypA attTn7::sypAE2A HA This Study 
KV7560 ΔsypA attTn7::sypAG25A HA This Study 
KV7562 ΔsypA attTn7::sypAD34A HA This Study 
KV7564 ΔsypA attTn7::sypAY64A HA This Study 
KV7566 ΔsypA attTn7::sypAE71A HA This Study 
KV7568 ΔsypA attTn7::sypAR74A HA This Study 
KV7570 ΔsypA attTn7::sypAG83A HA This Study 
KV7572 ΔsypA attTn7::sypAP99A HA This Study 
KV7559 ΔsypA ΔsypE attTn7::sypAE2A HA This Study 
KV7561 ΔsypA ΔsypE attTn7::sypAG25A HA This Study 
KV7563 ΔsypA ΔsypE attTn7::sypAD34A HA This Study 
KV7565 ΔsypA ΔsypE attTn7::sypAY64A HA This Study 
KV7567 ΔsypA ΔsypE attTn7::sypAE71A HA This Study 
KV7569 ΔsypA ΔsypE attTn7::sypAR74A HA This Study 
KV7571 ΔsypA ΔsypE attTn7::sypAG83A HA This Study 
KV7573 ΔsypA ΔsypE attTn7::sypAP99A HA This Study 
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Table 2: Plasmids used in this study 
Plasmids Description1 Reference 
   
pARM7 rscS overexpression plasmid; 
TetR 
[46] 
pARM47 Derivative of Tn7 delivery 
plasmid [45] pEVS107 
that contains sypE, KanR, ErmR 
[46] 
pARM163 Derivative of Tn7 delivery 
plasmid pEVS107 [45] that 
contains sypA-HA and its 
promoter 
[47] 
pCLD56 Derivative of low copy vector 
pKV282 that contains sypG 
[47] 
pCMT12 pARM47 containing rbdA (lac 
promoter only) 
This study 
pCMT14 pARM47 containing sypAVP (lac 
promoter only) 
This study 
pCMT16 pARM47 containing sypA (lac 
promoter only) 
This study 
pCMT19 pARM47 containing rbdA-HA  This study 
pCMT21 pARM47 containing sypAVP  This study 
pCMT22 pARM47 containing sypAVP-HA  This study 
pCMT23 pARM47 containing sypAE2A This study 
pCMT24 pARM47 containing sypAG25A This study 
pCMT25 pARM47 containing sypAD34A This study 
pCMT26 pARM47 containing sypAY64A This study 
pCMT27 pARM47 containing sypAE71A This study 
pCMT28 pARM47 containing sypAR74A This study 
pCMT29 pARM47 containing sypAG83A This study 
pCMT30 pARM47 containing sypAP99A This study 
pKV282 Low copy vector, TetR [46] 
1All derivatives of pARM47 contain the indicated gene and lack the sypE gene; except 
where indicated as “lac promoter only”, all pARM47 derivatives carry both the lac 
promoter and the sypA promoter. 
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Table 3: Oligonucleotides used in this study 
Gene/Promoter Sequence (5’ -3’) Primer 
   
sypA Gibson F GATTACGCCAAGCTTGCATGC 1727 
sypA Gibson R CAGTCTAGTTCTAGAGGGCCC 1728 
VV sypA F GATTACGCCAAGCTT GCATGCAACAGGAGAACGTCAC 1745 
VV sypA-flag R CAGTCTAGTTCTAGAGGGCCCTTTATCATCATCATCTTT 
ATAATCCTAAAACTGCTTGGAGTT 
1746 
VP sypA F GATTACGCCAAGCTT GCATGCTAAATGGAGATAGGGT 
C 
1747 
VP sypA-flag R CAGTCTAGTTCTAGA GGGCCCTTTATCATCATCATCTT 
TATAATCTTAGTGTCCTTTTGAATTG 
1748 
VV sypA-HA R CAGTCTAGTTCTAGAGGGCCCTTATGCATAATCTGGAA 
CATCATATGGATAAAACTGCTTGGAGTT 
1817 
VP sypA-HA R CAGTCTAGTTCTAGAGGGCCCTTATGCATAATCTGGAA 
CATCATATGGATAGTGTCCTTTTGAATTG 
1818 
sypA Gibson plac 
only F 
GATTACGCCAAGCTTGCATGCTTCCCTAGGAGCTTATT 
ATGG 
1820 
VV sypA Promoter R GTGACGTTCTCCTGTTGCATGCGCTCCTAGGGAATAAT 
CC 
1834 
VP sypA Promoter R GACCCTATCTCCATTTAGCATGCGCTCCTAGGGAATAA 
TCC 
1835 
sypA E2A F GCTTATTATGGCACTACATCAATTCGAATCAAATGA 1863 
sypA E2A R ATTGATGTAGTGCCATAATAAGCTCCTAGGGAATA 1864 
sypA G25A F GGACGCCATCGCATGTAGAGATATTCAACCATCCA 1865 
sypA G25A R TATCTCTACATGCGATGGCGTCCATATCACCTT 1866 
sypA D34A F ACCATCCATCGCAAGCGTGATTGAACAAGAACATC 1867 
sypA D34A R CAATCACGCTTGCGATGGATGGTTGAATATCTCTA 1868 
sypA Y64A F CGCTATTGTTGCACTATATAAACGACTTATAGAGAAA 1869 
sypA Y64A R GTTTATATAGTGCAACAATAGCGCCAATACCTGA 1870 
sypA E71A F ACGACTTATAGCAAAAGATCGTACTATGCAGATTAA 1871 
sypA E71A R TACGATCTTTTGCTATAAGTCGTTTATATAGATAAACA 1872 
sypA R74A F AGAGAAAGATGCAACTATGCAGATTAAAAATGCACA 1873 
sypA R74A R TCTGCATAGTTGCATCTTTCTCTATAAGTCGTTTATA 1874 
sypA G83A F AAATGCACATGCACAGCCACTAGAGTTACTAAAAC 1875 
sypA G83A R CTAGTGGCTGTGCATGTGCATTTTTAATCTGCATAG 1876 
sypA P99A F AAACGCAATTGCAGTTAATAAAACAACGCATTATCC 1877 
sypA P99A R TTTTATTAACTGCAATTGCGTTTTCAATACGTAGAA 1878 
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CHAPTER THREE  
EXPERIMENTAL RESULTS 
 
Ability of the sypA-like genes from Vibrio pathogens to promote biofilm 
formation by V. fischeri 
Introduction 
V. vulnificus and V. parahaemolyticus are two human pathogens that can cause 
serious infections in humans and can have particularly high mortality rates in the case of 
V. vulnificus. Several factors have been hypothesized to contribute to pathogenicity in 
both organisms, although the cause for the high mortality rates remains unclear. One 
hypothesis is that both bacteria can form a biofilm that in the human host can lead to 
persistent infection.  
The V. vulnificus genome includes a polysaccharide locus, rbd, that has been 
previously shown to be involved in aggregation, although individual genes of the locus 
have not been well characterized [4]. The rbd locus is conserved in the pathogen V. 
parahaemolyticus and in the non-pathogen V. fischeri, where it has been extensively 
characterized. In V. fischeri, this polysaccharide locus, called syp, is important in biofilm 
formation. The deletion of genes within the syp locus results in strains that no longer 
form a biofilm. Specifically, these strains do not produce wrinkled colonies, one readout 
of biofilm formation.  
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One of the regulators of biofilm formation in V. fischeri is SypA, a homolog of 
both RbdA, encoded by the first gene in the V. vulnificus rbd locus, and SypAVP, encoded 
by the first gene in the V. parahaemolyticus locus. The V. vulnificus RbdA protein has 
55% identity and 73% similarity to V. fischeri SypA (E value=4e-39) [48], which is 
required for syp-dependent biofilm formation in V. fischeri. The V. parahaemolyticus 
SypA-like protein has 58% identity and 73% similarity to V. fischeri SypA (E value=e-
43) [48] (Figure 3). When sypA is deleted in V. fischeri, biofilms do not form. The 
activity of SypA is negatively regulated via phosphorylation by SypE: when V. fischeri 
SypA is phosphorylated, no biofilm forms.  
The experimental goal is to elucidate the function of V. vulnificus RbdA and V. 
parahaemolyticus SypAVP. Because of the high degree of conservation between RbdA, 
SypAVP, and SypA and the tractability of the V. fischeri genome, this model of biofilm 
formation can be used to further our understanding of the function of rbd-encoded 
proteins and those encoded by V. parahaemolyticus. It is my hypothesis that because of 
the substantial sequence similarity, these proteins, RbdA and SypAVP, and SypA are 
orthologs. If the ability to promote biofilm formation is conserved in rbdA from V. 
vulnificus, and sypAVP from V. parahaemolyticus, then V. fischeri biofilm-deficient sypA 
mutant strains will form biofilms (wrinkled colonies) when the non-native genes are 
expressed. These experiments will give insight into the function of the SypA-like proteins 
in their own species and the role of STAS domain proteins in biofilm formation. 
34 
 
 
 
 
 
Figure 3. Alignment of SypA-like proteins. To determine the similarity between RbdA, 
SypAVP, and SypA, I aligned the three proteins [44]. The amino acid sequence is highly 
conserved around serine 56 which in V. fischeri SypA is phosphorylated by SypE, 
another protein encoded in the syp locus. 
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Ability of V. vulnificus rbdA and V. parahaemolyticus sypAVP to promote biofilm 
formation 
To being to determine the function of rbdA and sypAVP in biofilm formation in 
their own species, I assessed the ability of the two genes to promote biofilm formation by 
V. fischeri. I separately introduced a copy of the rbdA gene and the sypAVP gene at the 
Tn7 site in the chromosome of a V. fischeri strain deleted for sypA. I then induced strains 
to form a biofilm and assessed wrinkled colony formation. In these experiments, 
expression of rbdA and sypAVP was driven from the lac promoter alone. These constructs 
did not induce production of wrinkled colonies (Figure 4). I hypothesized that the lack of 
complementation may be due to insufficient levels of either RbdA or SypAVP.  
In biofilm formation assays, a ΔsypA V. fischeri strain that was complemented 
with sypA at the Tn7 site of the chromosome was used as a positive control for 
complementation. The sypA complemented strain produced wrinkled colonies; however, 
the sypA gene was expressed from two promoters, the lac promoter and the native sypA 
promoter. I therefore hypothesized that the lac promoter alone was insufficient to induce 
levels of SypA necessary for complementation. In support of this idea, when I expressed 
the native V. fischeri sypA from the lac promoter alone, I similarly did not observe 
wrinkled colony formation (Figure 5). 
Therefore, I engineered constructs in which the rbdA gene and the sypAVP gene 
were driven from the lac and sypA promoters, and I found that the complemented strains 
were able to form wrinkled colonies (Figure 6). The wrinkling appeared similar to a 
control strain that expressed the native V. fischeri sypA from the Tn7 site. However, 
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strains expressing sypAVP exhibited a slight delay in wrinkling. The SypAVP protein may 
function less efficiently due to changes in amino acids that in the native SypA are 
important for function. 
The data from the biofilm assay suggested that a threshold of SypA is required for 
biofilm formation. Western blotting was performed to compare SypAVP protein levels 
and native V. fischeri SypA levels (Figure 7). V. fischeri SypA appears to be produced 
more abundantly than SypAVP. Three microliters of extract containing SypA was loaded 
on the gel while six microliters of extract containing SypAVP was loaded on the gel. 
Interestingly, there was a difference in the migration of the V. fischeri and V. 
parahaemolyticus proteins, a finding that will be discussed in the Discussion section. 
Additionally, SypA protein was not visualized by Western blotting when expression of 
the sypA gene was driven by the lac promoter alone, a result that likely accounts for its 
inability to complement. 
In the laboratory, biofilm induction is usually induced in two ways: over-
expression of the response regulator, sypG or over-expression of the sensor kinase, rscS. 
In the above biofilm assays, I induced strains to form a biofilm by overexpressing sypG. 
In these strains, SypE, the negative regulator of SypA is absent. I also induced biofilm 
formation by overexpressing the sensor kinase rscS. In these strains, SypE is absent, and 
the sypA genes were expressed from the lac and sypA promoters. These strains, when 
induced to form a biofilm, did not form the robust wrinkled colonies that I previously 
observed using overexpression of sypG. The strains produced smooth colonies (Figure 8). 
Strains expressing sypAVP began to wrinkle, but even after prolonged incubation, these 
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strains did not appear similar to a positive control strain expressing V. fischeri sypA. 
These results suggest that over-expression of the sensor kinase rscS might not lead to 
sufficient production of SypA to produce wrinkled colonies. 
Although the exact function of SypA is unknown, it is likely that SypA interacts 
with other proteins to promote biofilm formation, potentially forming a complex with 
itself and/or other proteins. In strains that express RbdA or SypAVP, this hypothetical 
protein complex may not form correctly and/or may not work as efficiently as SypA-
expressing cells to promote biofilm formation. To test the hypothesis that the presence of 
RbdA or SypAVP may disrupt the interaction between SypA and itself or between SypA 
and other proteins in promoting biofilm formation, I moved either rbdA or sypAVP into a 
strain containing the native V. fischeri sypA. In these experiments, strains not expressing 
rbdA or sypAVP wrinkle due to the presence of V. fischeri sypA. I expected that a strain 
that expressed sypA and rbdA or sypA and sypAVP would produce smooth colonies if the 
homologous proteins impaired the function of SypA. However, I found that rbdA and 
sypA expressing strains produced wrinkled colonies (Figure 9). Wrinkling appeared 
similar to strains expressing two alleles of V. fischeri sypA. Additionally, there was no 
difference in the timing of wrinkling. These data suggest that if SypA is interacting with 
itself or other proteins to promote biofilm formation, RbdA and SypAVP do not disrupt 
this interaction. This level of regulation could help to ensure biofilm formation occurs at 
the proper place and time in the environment. 
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Figure 4. Neither rbdA nor sypAVP, when expressed from a single promoter, 
promotes biofilm formation. A wrinkled colony assay was performed with strains 
deficient for sypA and sypE and expressing rbdA and sypAVP from the chromosome. Gene 
expression was driven by the lac promoter. Biofilm induction was achieved by over-
expressing the gene for the response regulator, sypG. Pictures were taken at the indicated 
time points. 
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Figure 5. Biofilm production depends on sypA expression from two promoters. A 
wrinkled colony assay was performed with strains deficient for sypA and sypE expressing 
sypA from either the lac promoter alone or the lac and sypA promoters. Biofilm induction 
was achieved by over-expressing the gene for the response regulator, sypG. Pictures were 
taken at the indicated time points.  
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Figure 6. rbdA and sypAVP expressed from two promoters promote biofilm 
formation. A wrinkled colony assay was performed with strains deficient for sypA and 
sypE and expressing either rbdA or sypAVP from the chromosome. Gene expression was 
driven by the lac and sypA promoters. Biofilm induction was achieved by over-
expressing the gene for the response regulator, sypG. Pictures were taken at the indicated 
time points.  
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Figure 7. SypA migrates to a higher molecular weight than SypAVP. Whole cell 
lysates were electrophoresed on an SDS-PAGE gel. Proteins were visualized using rabbit 
anti-HA primary antibody and a donkey anti-rabbit IgG HRP-conjugated secondary 
antibody. The first lane contains an extract from V. fischeri ΔsypA expressing SypA-HA 
(3 µl loaded). The second lane contains an extract from V. fischeri ΔsypA expressing 
untagged SypA (3 µl loaded). The third lane contains an extract from V. fischeri ΔsypA 
expressing V. parahaemolyticus SypAVP-HA (6 µl loaded).  
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Figure 8. Biofilm induction by RscS does not promote biofilm formation of strains 
expressing rbdA or sypAVP. A wrinkled colony assay was performed with strains 
deficient for sypA and sypE and expressing rbdA or sypAVP from the chromosome. Gene 
expression was driven by the lac and sypA promoters. Biofilm induction was achieved by 
over-expressing the gene for the sensor kinase, rscS. Pictures were taken at 41, 51, and 66 
hours. 
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Figure 9. Co-expression of rbdA or sypAVP with sypA does not impact biofilm 
formation. A wrinkled colony assay was performed with strains deficient for sypE and 
expressing rbdA and sypA or sypAVP and sypA. Gene expression of rbdA and sypAVP was 
driven by the lac and sypA promoters. Biofilm induction was achieved by over-
expressing the gene for the response regulator, sypG. Pictures were taken at the indicated 
time points. 
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Summary 
The goal of this study was to elucidate the function of V. vulnificus RbdA and V. 
parahaemolyticus SypAVP. I hypothesized that because of the substantial sequence 
similarity, these proteins, RbdA and SypAVP, and SypA are orthologs. If the ability to 
promote biofilm formation is conserved in rbdA from V. vulnificus, and sypAVP from V. 
parahaemolyticus, then V. fischeri biofilm-deficient sypA mutant strains will form 
biofilms (wrinkled colonies) when the non-native genes are expressed. I determined that 
rbdA and sypAVP have the ability to promote biofilm formation in V. fischeri as both 
genes were able to functionally complement a sypA-deficient V. fischeri strain for biofilm 
formation. These results suggest that RbdA and SypAVP may play a similar role in 
promoting biofilm formation in their own species. Complementation appears to depend 
on the presence of a minimal level of protein as expression of genes driven from the lac 
promoter alone was not enough to produce wrinkled colonies. Strains only produced 
wrinkled colonies when gene expression was driven from the lac and syp promoters. 
Wrinkled colonies were only observed when strains were induced to form a biofilm by 
overexpression of sypG. Cells overexpressing rscS did not produce the same wrinkled 
colonies. These experiments indicate there may be differences between SypA proteins, 
and provide insights into SypA function. Overall, these results validate this approach as 
one that can provide insights into the function of homologous genes from related species. 
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Ability of the SypA-like proteins from Vibrio pathogens to serve as a 
substrate for phosphorylation by V. fischeri SypE 
Introduction 
It has previously been shown that SypA is regulated by phosphorylation at a 
specific serine residue by another protein encoded within the syp locus, SypE [32]. When 
active, SypE phosphorylates SypA, inactivating it and inhibiting biofilm formation. 
When SypE is inactive, SypA is unphosphorylated and can promote biofilm formation. 
Like SypA, RbdA and SypAVP each contain a serine residue, predicted to be the site of 
phosphorylation, that is highly conserved in STAS domain proteins. Not only is the 
serine conserved, but many surrounding amino acid residues are conserved between the 
three proteins. Thus, it is possible that RbdA and SypAVP are also phosphorylated. 
Furthermore, it is plausible that SypE can recognize and phosphorylate RbdA and 
SypAVP due to the high conservation not only of the serine but also the surrounding 
amino acids. However, neither V. vulnificus nor V. parahaemolyticus have a SypE 
homolog, suggesting that the ability to be phosphorylated may not be conserved. 
Alternatively, it is possible that another serine kinase, distinct from SypE, could 
phosphorylate these proteins. Given the serine conservation as well as the sequence 
conservation between SypA, RbdA, and SypAVP, I hypothesize that the SypA-like 
proteins can be phosphorylated by SypE; if so, they may also be regulated by 
phosphorylation in their native organism. The studies in this section are designed to test 
this hypothesis. 
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Ability of V. vulnificus RbdA and V. parahaemolyticus SypAVP to be controlled by 
SypE 
My previous biofilm studies made use of strains in which the biofilm inhibitor 
SypE, which phosphorylates and thus inactivates SypA, was missing or inactivated. Here, 
I assessed the ability of SypE to control the activity of RbdA and SypAVP using a genetic 
approach. I assessed biofilm formation in a sypA-deficient strain expressing not only 
rbdA or sypAVP but also sypE. If SypE can recognize and phosphorylate these SypA 
homologs, smooth colonies will be produced. Alternatively, if the SypA homologs cannot 
be controlled by SypE, wrinkled colonies will be produced even in the presence of the 
biofilm inhibitor.  
As previously observed, strains expressing V. fischeri sypA and its negative 
regulator sypE produce smooth colonies when induced to form a biofilm (Figure 10). In 
contrast, a control strain expressing sypE and a mutant V. fischeri sypA allele that cannot 
be phosphorylated produced wrinkled colonies when induced to form a biofilm. When 
either rbdA or sypAVP was co-expressed with sypE in a strain deficient for sypA, smooth 
colonies were produced (Figure 10). At later time points, strains co-expressing rbdA and 
sypE exhibited a partial wrinkling phenotype. These data suggest RbdA is inactivated by 
SypE but inactivation may be inefficient or overcome with time.  
Data suggesting that RbdA is controlled by SypE led to the hypothesis that RbdA 
could serve as the preferred target for SypE’s inhibitory activity, thus sequestering SypE 
and freeing SypA to promote biofilm formation. To test if RbdA or SypAVP could be 
preferentially inhibited by SypE, allowing SypA to promote biofilm formation, I 
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expressed sypA, and sypE, along with either rbdA or sypAVP, in V. fischeri and induced 
biofilm formation using SypG (Figure 11). Strains expressing rbdA or sypAVP with sypA 
and sypE did not wrinkle, suggesting that the non-native proteins do not interact more 
strongly with SypE than SypA and that both proteins are likely inactivated by 
phosphorylation. 
  
48 
 
 
 
 
 
 
 
 
Figure 10. Function of RbdA and SypAVP is controlled by SypE. A wrinkled colony 
assay was performed with strains deficient for sypA and expressing sypE and rbdA or 
sypAVP. Gene expression of rbdA and sypAVP was driven by the lac and sypA promoters. 
Biofilm induction was achieved by over-expressing the gene for the response regulator, 
sypG. Pictures were taken at the indicated time points. 
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Figure 11. Co-expression of rbdA or sypAVP with sypA in the presence of sypE does 
not promote biofilm formation. A wrinkled colony assay was performed with strains 
expressing sypE and rbdA and sypA or sypAVP and sypA. Gene expression of rbdA and 
sypAVP was driven by the lac and sypA promoters. Biofilm induction was achieved by 
over-expressing the gene for the response regulator, sypG. Pictures were taken at 25, 50, 
and 67 hours.  
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Genetic studies suggested that SypE controls RbdA. To test if this control is due 
to phosphorylation of RbdA, as is the case with V. fischeri SypA, I tried to visualize the 
RbdA by phos-tag gels and Western blotting. The phos-tag reagent retards the migration 
of phosphorylated proteins by preferentially binding to phosphorylated proteins, thus 
separating phosphorylated proteins from unphosphorylated proteins, resulting in a band 
shift observable following gel electrophoresis and western blotting. However, I have been 
unable to visualize bands correlating to RbdA and SypA in the presence of a vector or 
SypE in E. coli when visualizing protein by phos-tag. Furthermore, when I have observed 
the proteins, no shift was evident, even with my native SypA-HA control. SypA has 
previously been shown to be phosphorylated via phos-tag when SypA was GST-tagged 
[32]. If a shift can be visualized between the GST-tagged SypA in the presence of vector 
vs. SypE but not with untagged SypA, then it is likely that SypA, and therefore SypAVP 
and RbdA, will need to be GST-tagged to observe the phosphorylated state. If I obtain 
this result, future directions beyond the scope of my thesis would be to generate larger 
fusion protein with RbdA and SypAVP and then assess their phosphorylation state.  
Given the sequence similarities—V. parahaemolyticus SypAVP also has a 
conserved serine that could be phosphorylated—I hypothesized that this protein may also 
be recognized and phosphorylated by SypE. Either phosphorylation or physical 
interaction between SypE and SypAVP could account for the ability of SypE to inhibit 
SypAVP-induced biofilm formation. To test if SypAVP is inhibited by phosphorylation by 
SypE, I visualized SypAVP by phos-tag. Preliminary data has shown the SypAVP may be 
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phosphorylated. It is difficult to tell, however, since the positive control for band shift, 
phosphorylated SypA, was not be visualized by Western blot.  
Summary 
 Given their sequence similarity and their ability to complement a sypA mutant, I 
hypothesized that RbdA and SypAVP are true orthologs of SypA. If so, then they should 
be susceptible to control by SypE. I hypothesized that when sypE is expressed in strains 
complemented with either rbdA or sypAVP, the strains will no longer produce wrinkled 
colonies. I found this to be true; strains expressing either rbdA or sypAVP failed to form a 
biofilm in the presence of SypE. This result is the same as when sypE is expressed with 
the native sypA, because SypA becomes phosphorylated and thus inactivated. These 
results suggest that SypE is able to control the functions of RbdA or SypAVP potentially 
by phosphorylation. It is interesting that V. vulnificus and V. parahaemolyticus do not 
have SypE homologs, but are still sensitive to SypE. It is formally possible that SypE 
does not phosphorylate RbdA or SypAVP, but rather binds to these proteins, physically 
preventing them from interacting with other proteins to promote biofilm formation. 
Future work is necessary to distinguish amongst these possibilities. 
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Identify specific residues important for biofilm formation and for 
recognition and phosphorylation by SypE 
Introduction 
 Both rbdA and sypAVP were able to promote biofilm formation in a strain in which 
the native sypA was absent, suggesting that amino acids important for interaction with 
SypA’s partner in promoting biofilm formation are conserved in all three species. In 
addition, RbdA and SypAVP also appeared to be susceptible to regulatory control by 
SypE. Thus, amino acids important for (1) biofilm formation and (2) interaction with 
SypE must be conserved in all three species. Mutating amino acids in SypA important for 
interaction with a putative downstream partner would disrupt biofilm formation, while 
mutations that impact its interaction with SypE could result in a protein that is blind to 
SypE’s inhibitory effects. Mutagenesis of SypA could result in null mutants. These 
mutants could provide insight into amino acids that are required for the stability of the 
protein. 
Identification and mutation of conserved amino acids 
To determine the similarity between the proteins, I first compared the amino acid 
sequence of V. vulnificus RbdA, V. parahaemolyticus SypAVP, and V. fischeri SypA and 
identified amino acids conserved in all three proteins (Figure 12) [44]. I then compared 
the conserved amino acids in the SypA-like proteins to other STAS domain proteins and 
chose to mutate amino acids that were not conserved in other STAS domain proteins 
(Data not shown). The amino acids that are conserved in Vibrio species, but not in other 
unrelated STAS domain proteins, could be critical for RbdA’s function in promoting 
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biofilm formation and/or in interacting with SypE. I generated point mutations in codons 
for conserved amino acids that I hypothesized to be important for biofilm formation in an 
allele of sypA and introduced copies of the genes into the Tn7 site in the V. fischeri 
chromosome to assess biofilm formation and interaction with SypE. 
  
54 
 
 
 
 
 
 
 
Figure 12. SypA point mutations. In red are mutations that I have made. In blue are 
mutations previously made in the lab. Above the amino acid sequence is the secondary 
structure of the SypA protein as predicted by threading the protein onto another known 
STAS domain protein [44]. 
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Investigation into the roles of conserved amino acids in promoting biofilm formation 
I generated eight sypA alleles with a single point mutation. I chose to mutate 
residues to alanine as alanine is non-bulky and least affects protein secondary structure. 
The mutations were confirmed by sequence analysis using ACGT, inc (Wheeling, IL). I 
then performed a sensitive time course assay and found six amino acids that are important 
for promoting biofilm formation. Interestingly, some amino acids appeared to be more 
important than others as there were a range of defects (Figure 13). Some mutants were 
delayed for biofilm formation while others failed to form a biofilm altogether. Strains that 
expressed SypA with either of two amino acid mutations, E2A and Y64A, were delayed 
and defective for biofilm formation. Even after days of growth, these mutants never 
formed wrinkled colonies similar to the positive control. Yet another strain, expressing 
SypA-D34A, was completely defective for biofilm formation, never producing wrinkled 
colonies. Strains expressing SypA-R74A or SypA-G83A, had short delays in biofilm 
formation, but produced normal wrinkled colonies at later time points. The SypA-E71A-
expressing strain produced wrinkled colonies with a normal timing and pattern, but the 
colonies attached poorly to the plate, indicating some defect in biofilm development. 
Finally, strains expressing either SypA-G25A or SypA-P99A did not exhibit any defect, 
suggesting that those amino acids are not required for biofilm formation under these 
conditions. 
In addition to the eight mutations I made, four other mutations have been made in 
SypA by a previous member of the lab. Three of the four mutations resulted in strains 
that no longer produced wrinkled colonies. When assessed in conjunction with the 
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mutants I have generated, we can determine what part(s) of the protein is important for 
function in forming the biofilm. Using Cn3D [49], an application used to view the 3-
dimensial structures of proteins, I visualized the location of the mutations in SypA that 
resulted in a biofilm-defective phenotype. Many of these mutations are located on the 
same face of two alpha helices. This face of the protein may interact with another protein 
to promote biofilm formation. I hypothesize that, when these amino acids are changed, 
SypA can no longer interact with its putative partner. 
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Figure 13. SypA point mutants have a range of effects on biofilm formation. A 
wrinkled colony assay was performed with strains deficient for sypA and sypE and 
expressing the mutant sypA. Biofilm induction was achieved by over-expressing the gene 
for the response regulator, sypG. Pictures were taken at the indicated time. 
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Investigation into the roles of conserved amino acids in recognition and 
phosphorylation by SypE 
The activity of SypA is negatively controlled via phosphorylation by SypE. To 
date, Serine 56 is the only residue known to be critical for the ability of SypE to 
recognize and control SypA’s activity. I predicted that other residues are also important 
for the interaction between SypA and SypE. I anticipated that mutations that change 
amino acids in SypA important for recognition by SypE will result in a SypA protein no 
longer recognized and/or phosphorylated by SypE. When introduced into a strain that 
expresses SypE, a mutant SypA that fails to interact with SypE will overcome its 
inhibition activity, permitting biofilm formation under conditions in which it typically 
does not occur.  
I expect SypA mutants with changes in amino acids that are important for 
recognition and phosphorylation by SypE will promote the formation of wrinkled 
colonies even when the genetic background results in the production of inhibitory SypE. 
However, thus far strains expressing SypA with any of the eight mutations I have 
generated have produced smooth colonies in the presence of SypE, suggesting these 
mutant SypA proteins are still susceptible to control by SypE (Figure 14).  
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Figure 14. SypA point mutations are susceptible to control by SypE. A wrinkled colony 
assay was performed with strains deficient for sypA and expressing the mutant sypA as well 
as sypE. Biofilm induction was achieved by over-expressing the gene for the response 
regulator, sypG. Pictures were taken at 24 and 48 hours. 
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Summary 
 I hypothesized that amino acids important for biofilm formation must be 
conserved in the three homologous STAS domain proteins, RbdA, SypAVP, and SypA as 
all three proteins are able to promote biofilm formation. I identified conserved resides 
and generated mutations in which these resides were changed to alanine. When assessed 
for biofilm formation in a V. fischeri ΔsypA strain, some mutations result in delayed and 
defective wrinkled colonies. Other mutations only resulted in delayed wrinkled colony 
formation. Changes in SypA residues important for interaction with other proteins may 
prevent interactions from occurring thereby by inhibiting biofilm formation. The amino 
acids mutations I have made thus far do not have any effects on the ability of SypE to 
recognize and phosphorylate SypA. These mutants can be used in further studies to 
elucidate the function of SypA and identify other proteins SypA may interact with to 
promote biofilm formation.
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CHAPTER FOUR  
DISCUSSION 
 
 In this thesis, I investigated the function of the SypA-like proteins encoded by the 
pathogenic Vibrio species V. vulnificus and V. parahaemolyticus using the non-
pathogenic relative, V. fischeri. The V. fischeri model of biofilm formation utilizes a 
readily visualized phenotype, wrinkled colonies, to determine the contribution of specific 
genes to biofilm formation. When genes important for biofilm formation such as sypA are 
deleted, strains produce smooth colonies. Genes, such as rbdA or sypAVP, can easily be 
moved into the chromosome to assess their ability to promote biofilm formation. This 
work has revealed that RbdA and SypAVP function similarly to V. fischeri SypA in 
promoting biofilm formation, producing wrinkled colonies. The ability to promote 
biofilm formation and produce wrinkled colonies must be conserved in the proteins of all 
three organisms. In the course of this work, I also obtained unexpected findings that have 
permitted a greater understanding of the role of the STAS domain protein, SypA, in 
biofilm formation. 
Single promoter vs. dual promoter expression of SypA 
My work revealed that expression of V. fischeri sypA (and, similarly, of rbdA or 
sypAVP) from the lac promoter alone was insufficient to promote biofilm formation. This 
was somewhat surprising, as the lac promoter (alone) has been sufficient to promote gene 
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expression of other genes in previous complementation studies, resulting in biofilm 
formation [50]. In contrast, when sypA was expressed from the lac promoter as well as 
the sypA promoter, strains produced wrinkled colonies; whether both promoters are 
required for optimal expression of the non-native syp genes, or merely the native V. 
fischeri sypA promoter is yet unknown.  
There are several possibilities that may account for the results I observed. sypA 
expression from the lac promoter alone may not complement a V. fischeri sypA deletion 
strain because there may not be sufficient levels of sypA transcript present needed to 
produce high levels of protein. In support of this possibility, I was unable to detect SypA 
protein from V. fischeri expressing native sypA from the lac promoter alone via Western 
blot. However, these data don’t exclude alternative possibilities. For example, the lac 
promoter may produce sufficient levels of sypA messenger RNA, but the sypA messenger 
RNA transcripts may be unstable and degraded before the transcript can be translated into 
SypA protein. Such instability could be due to the presence, in the lac-driven sypA 
transcript, of a sequence that signals degradation of the transcript or that forms a 
secondary structure, such as a stem loop, that prevents translation. Another possibility is 
that there’s temporal control over the lac promoter: it is presumed to be constitutively 
active, producing sypA transcripts and thus SypA protein during log and lag phase, but 
perhaps it doesn’t function well during stationary phase, the phase during which biofilm 
formation occurs. It remains to be determined which of these various possibilities 
accounts for the failure of the lac promoter-driven rbdA and sypAVP to complement the 
sypA mutant. 
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Aberrant migration of V. fischeri SypA 
I found that the migration of the SypA-HA in a SDS gel differed from that of 
SypAVP-HA, with SypAVP migrating to the position expected for both proteins. For SDS-
PAGE and Western blot preparation, SypA samples are lysed in 2X sample buffer 
containing sodium dodecyl sulfate (SDS) and β-mercaptoethanol and boiled, after which 
samples are run on SDS gels. SDS denatures proteins by disrupting non-covalent bonds 
causing proteins to lose their native conformation. β-mercaptoethanol is a reducing agent 
that has the ability to disrupt the structure of proteins by breaking disulfide bonds 
between proteins. Thus, the altered migration of SypA may not be due to a non-covalent 
interaction, or else not due to a protein-protein interaction.  
Based upon the observation that SypA protein migrates to a higher molecular 
weight than predicted, I speculate that SypA may be forming a covalently bonded 
complex with itself, or potentially be modified by another molecule such as a lipid or 
polysaccharide. Various treatments can be applied to the cells, prior to evaluating the 
migration of SypA, to determine the nature/stability of a putative interaction or 
modification. This could provide insight into what SypA is interacting with and how it is 
functioning to promote biofilm formation. This interaction may not be important for 
biofilm formation, however, as SypAVP migrates as predicted for its molecular weight yet 
still promotes biofilm formation. Thus, this analysis could identify a previously unknown 
function of SypA. 
SypA interaction with other molecules 
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Previous studies have determined that SypA is unlikely to act as an anti-sigma 
factor antagonist (Sheila McEwen and Karen Visick, personal communication), and thus 
how SypA functions remains unclear. Because there appears to be a minimum amount of 
SypA required to promote biofilm formation, I speculate that SypA is a structural protein, 
rather than a regulator. Potentially, SypA could interact with other proteins within a 
stressosome complex, like RsbR and RsbS [35]. Identifying the other protein(s) with 
which SypA interacts is an important step in understanding SypA function. I anticipate 
that, if SypA functions within a stressosome, or as part of another complex, the same will 
be true for RbdA and SypaVP since these non-native proteins can promote biofilm 
formation in V. fischeri. 
  One method that can be used to elucidate SypA’s binding partner is a Far-Western 
[51]. In this method, SypA would be used as a non-antibody probe to identify protein-
protein interactions in a cell lysate. V. fischeri cell lysate is electrophoresed on a native 
gel. Purified, epitope-labelled SypA that can be detected using an antibody is used to 
probe and detect a target on the membrane. The resulting band on the gel observed after 
probing corresponds to the protein interacting with SypA. Alternatively, specific 
candidate partners can be tested more directly using co-immunoprecipitation. When sypA 
is not active, there is no polysaccharide production (Visick, personal communication), 
suggesting SypA interacts with other proteins within the Syp pathway. Thus, co-
immunoprecipitation assays with epitope-tagged Syp proteins can be performed to 
determine direct interactions between SypA and other Syp proteins. 
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 In addition to interacting with a partner to facilitate biofilm formation, it is 
possible that SypA may also bind GTP and/or may have GTPase activity. STAS domain 
proteins from other bacterial species have been shown to bind and hydrolyze GTP in 
addition to performing other functions. For example, the STAS domain protein Rv1739c 
from M. tuberculosis has GTP binding and hydrolyzing capabilities [36]. The STAS 
domain protein SpoIIAA of B. subtilis also has reported GTP binding and hydrolyzing 
activity, although the consequence of this activity has yet to be determined [52]. 
Comparisons can be made between SypA and STAS domain proteins known to bind GTP 
to determine if amino acids known to be shifted upon GTP binding are conserved in 
SypA. If the ability to bind GTP is a common function of STAS proteins, then SypA 
might behave similarly. If SypA binds GTP, then one of the mutants that I generated may 
be defective for this activity. Future work can determine if SypA binds GTP and, if so, 
whether that activity is important for biofilm formation and/or interactions with SypE. 
 Because of the conserved ability of RbdA and SypAVP to promote biofilm 
formation, it is plausible that any additional function of V. fischeri SypA is also 
conserved. If V. fischeri has GTP binding or GTPase activity, then it is possible that these 
functions are conserved in the proteins of other species and that RbdA and SypAVP could 
be have GTP binding or GTPase activity. Further studies could determine the impact(s) 
of these additional functions have on biofilm formation and the pathogenesis of either V. 
vulnificus and V. parahaemolyticus. 
SypA point mutants 
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I have identified conserved amino acids that are important for the ability of SypA 
to promote biofilm formation. I generated point mutations in codons for conserved amino 
acids that I hypothesized to be important for biofilm formation, and found that a subset of 
these mutations did, in fact, disrupt biofilm formation in complementation experiments.  
In complementation experiments, SypA point mutations had a range of effects on 
biofilm formation. While some mutations resulted in proteins with diminished function, 
others could no longer promote biofilm formation. These loss of function alleles may not 
promote biofilm formation for several reasons. One reason for the lack of biofilm 
formation may be that the mutant SypA protein may not be produced. The SypA mutants 
I generated are epitope tagged, and thus Western blotting can be performed to determine 
if the protein is made.  
One approach that may provide some insight into whether SypA is folded is 
evaluating the ability of SypE to phosphorylate SypA; if the mutant SypA is able to be 
phosphorylated by SypE, it would suggest the protein is adequately folded to permit 
SypE to recognize and phosphorylate SypA. If the mutant SypA cannot be 
phosphorylated, it may be due to improper SypA folding. 
The positions of amino acids that are required for biofilm formation can be 
analyzed using Cn3D [49], an application used to view the 3-dimensial structures of 
proteins. When I visualized the location of the mutations in SypA that resulted in a 
biofilm-defective phenotype, I found that three mutations, tyrosine 64, lysine 67, and 
arginine 68, are located on the same face of one alpha helix. The amino acids on this face 
of the protein may interact with another protein to promote biofilm formation. I 
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hypothesize that, when these amino acids are changed, SypA can no longer interact with 
its putative partner. Four additional amino acids are located on the same face of the alpha 
helix as these required amino acids including glycine 60, leucine 65, leucine 69, and 
isoleucine 70. These residues may provide points of contact between SypA and another 
protein, and this interaction may promote biofilm formation. Substitution of these 
residues with alanine may prevent contact between SypA and its partner, this inhibiting 
biofilm formation. 
In addition to loss of function mutants, some mutations may result in proteins 
with enhanced function. Strains expressing alleles that have enhanced function might 
form biofilms at earlier time points than wild-type strains. Alternatively, point mutant 
strains may form an enhanced biofilm due to increased adherence of the cells. This 
phenotype has been observed previously in the lab (Ondrey and Visick, personal 
communication): cells of control strain adhere to each other during biofilm formation, but 
cells of strains that form enhanced biofilms adhere not only to each other but to the agar 
plate as well. I observed that some of my strains that expressed a mutant allele of sypA 
adhered to the plate, suggesting that changes in some amino acids may result in a SypA 
protein with an enhanced ability to promote biofilm formation. However, whether this 
altered adherence actually represents an enhanced or a defective biofilm has yet to be 
determined. 
Some mutants were more defective for biofilm formation than others. These SypA 
mutants that produce smooth colonies when induced to form a biofilm can be used in 
further studies to find suppressor mutants. These strains can be mutagenized by UV 
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radiation, and mutagenized strains that are able to restore wrinkling contain either 
revertant or suppressor mutations. The genome of these mutant strains that are able to 
restore biofilm formation can be analyzed to determine the location of the mutation. If the 
mutant is a suppressor mutant, it could give insight into what protein(s) SypA is 
interacting with and how it is functioning. 
Function and control of RbdA and SypAVP 
In complementation experiments, rbdA and sypAVP were able to promote biofilm 
formation. The ability to produce wrinkled colonies in V. fischeri suggests that both 
RbdA and SypAVP are performing similar roles in promoting biofilm formation as V. 
fischeri SypA. Thus, the function of this STAS domain protein has been conserved 
among the species. RbdA and SypAVP may be functioning in a similar way to promote 
biofilm formation in their own species. Furthermore, the V. fischeri model of biofilm 
formation can be used to assess the function of genes from related species. 
While rbdA and sypAVP were able to promote wrinkled colony formation in strains 
induced by sypG, they did not do so in strains induced by rscS. The difference observed 
under the two conditions may be due to the amount of transcript produced, as it is known 
that sypG is a stronger inducer of biofilm formation. Alternatively, the difference may be 
due to the position of the ribosomal binding site in the non-native sypA genes. The 
plasmid constructs containing the non-native genes contain the ribosomal binding sites 
for V. vulnificus and V. parahaemolyticus, which may not be optimal for V. fischeri. 
Overexpression of sypG might induce enough transcription to overcome the effects of the 
non-optimal ribosomal binding site, but overexpression of rscS, which does not induce 
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syp transcription to the same extent as does sypG, may not be able to overcome this 
potential decreased translation. Biofilms induced by rscS may not produce enough rbdA 
or sypAVP to meet the minimum amount of protein required to promote biofilm formation. 
Experiments are on-going to determine if this trivial explanation can account for the 
dramatic differences in complementation depending whether sypG or rscS is 
overexpressed. If it doesn’t, then I would conclude that the differences in 
complementation are due to differences in functionality of the protein. The non-native 
SypA produced may not function as well as the native SypA due to differences between 
the proteins. The abundance of the sub-optimally functioning protein, which occurs 
during sypG induction of biofilms, may be able to overcome deficits in biofilm 
formation. 
My work also showed that the ability of RbdA and SypAVP to be controlled by 
SypE is conserved, although V. vulnificus and V. parahaemolyticus have lost the gene for 
the SypE homolog. However, my current results do not demonstrate that SypE retains the 
ability to phosphorylate these non-native proteins. An alternative hypothesis is that SypE 
retains the ability to bind and thus sequester the SypA homologs, preventing their 
biofilm-promoting activity. If SypE can phosphorylate these proteins, and 
phosphorylation is indeed key to controlling their activity (as assessed with mutants with 
changes at the conserved site of phosphorylation), then it is possible that, in V. vulnificus 
and V. parahaemolyticus, another kinase may perform the function of SypE.  
Significance 
70 
 
 
 
My work demonstrates that the function of the SypA STAS domain protein is 
conserved among three Vibrio species, V. vulnificus, V. parahaemolyticus, and V. 
fischeri. While the precise function(s) of these STAS domain proteins remains unclear, 
they all can function in promoting biofilm formation by V. fischeri. It is important to 
understand the function of SypA as it plays a crucial role in biofilm formation. Because 
rbdA and sypAVP can complement a V. fischeri mutant, it is likely that RbdA and SypAVP 
are similarly required for biofilm formation in their own species, pathogenic bacteria 
whose ability to cause disease may depend on biofilm formation.  
Unlike the best-characterized bacterial STAS domain proteins (e.g., SpoIIAA and 
RsbV [35]), SypA does not appear to function as an anti-sigma factor antagonist. Further 
work elucidating the function of SypA will contribute to our understanding of the role of 
STAS domain proteins in signaling and in other cell processes. My work has advanced 
our understanding of SypA as we now know that SypA must be present at sufficient 
levels to promote biofilm formation, suggesting it may have a structural rather than 
regulatory role. Additionally, my evidence suggests that SypA may have unusual 
properties and/or may be modified, as it runs aberrantly in an SDS gel.  
Previous studies have shown that the rbd locus in V. vulnificus contributes to 
aggregation [4], however, individual genes of the locus have not been studied. This locus 
is conserved in V. parahaemolyticus, but no studies of its function have been reported. 
Determining the contribution of individual genes in either locus to biofilm formation is 
an important step in understanding how V. vulnificus and V. parahaemolyticus biofilms 
form. We can use the V. fischeri model of biofilm formation to determine the function of 
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genes from V. vulnificus and V. parahaemolyticus by complementing a mutant V. fischeri 
strain. My work has shown that rbdA and sypAVP are able to complement a V. fischeri 
mutant indicating a conservation in function between these proteins. It is likely that RbdA 
and SypAVP are required for biofilm formation in their own species as well.  
As potential regulators of biofilm formation, RbdA and SypAVP and the 
complexes they may form could serve as a potential target for an inhibitor of biofilm 
formation. An inhibitor of V. vulnificus or V. parahaemolyticus biofilms could serve 
many purposes. While there exist many treatments options for removing bacteria from 
the oyster population, few treatments effectively remove all the bacteria. Treatments that 
are effective are costly. When treatments are not effective and bacteria persist in the 
oyster population, increased human transmission and infection due to bacterial 
contamination can occur. Outbreaks can lead to recall of oysters which can be financially 
devastating to the oyster industry. An inhibitor of biofilm formation could be used as a 
treatment to effectively remove bacteria from oyster populations harvested for human 
consumption. This inhibitor could target a potential regulator of biofilm formation such 
as RbdA in V. vulnificus or SypAVP in V. parahaemolyticus. Inhibitors of V. vulnificus or 
V. parahaemolyticus biofilms could also be used to treat humans infected with either 
organism. Drugs that prevent the formation of a V. vulnificus biofilm in a susceptible 
individual could drastically improve patient outcome. 
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